Medicine & Life Sciences
Multiple Sclerosis
100%
Tuberous Sclerosis
35%
Holoprosencephaly
29%
Natalizumab
28%
Cerebral Palsy
24%
Therapeutics
24%
Child
19%
Central Nervous System
18%
Central Nervous System Diseases
17%
Autoimmune Diseases of the Nervous System
17%
Neuromyelitis Optica
17%
Relapsing-Remitting Multiple Sclerosis
16%
abobotulinumtoxinA
16%
T-Lymphocytes
16%
Glioblastoma
14%
Glatiramer Acetate
14%
Autoimmune Experimental Encephalomyelitis
14%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13%
B-Lymphocytes
12%
Chronic Progressive Multiple Sclerosis
12%
epidermal growth factor receptor VIII
11%
Astrocytoma
11%
Brain
11%
ErbB Receptors
11%
Carbamazepine
10%
Mutation
10%
Cerebrospinal Fluid
10%
Epilepsy
10%
Safety
9%
Everolimus
9%
Genes
8%
Autoimmunity
8%
Phenotype
8%
Angiomyolipoma
8%
Glioma
8%
Neoplasms
8%
Placebos
7%
Pharmaceutical Preparations
7%
Interferon-beta
7%
Progressive Multifocal Leukoencephalopathy
7%
quinpramine
7%
Seizures
7%
Type A Botulinum Toxins
7%
Pediatrics
7%
Demyelinating Diseases
6%
Rituximab
6%
Somatosensory Evoked Potentials
6%
Immunosuppressive Agents
6%
Acute Disseminated Encephalomyelitis
6%
Fingolimod Hydrochloride
6%
Clinical Trials
6%
siponimod
6%
Incidence
6%
Injections
6%
N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
6%
Receptor-Interacting Protein Serine-Threonine Kinases
6%
Upper Extremity
6%
Neuroimaging
6%
Alemtuzumab
6%
Interferons
5%
Mitoxantrone
5%
Oligodendrocyte-Myelin Glycoprotein
5%
4-dichlorobenzene
5%
teriflunomide
5%
Aquaporin 4
5%
Systematic Reviews
5%
Recurrence
5%
MHC class II transactivator protein
5%
Biomarkers
5%
Prion Proteins
5%
Valproic Acid
5%
Immunization
5%
Monoclonal Antibodies
5%
Intellectual Disability
5%